Literature DB >> 12919674

Control of skeletal patterning by ephrinB1-EphB interactions.

Amelia Compagni1, Malcolm Logan, Rüdiger Klein, Ralf H Adams.   

Abstract

We report that targeted inactivation of the Eph receptor ligand ephrinB1 in mouse caused perinatal lethality, edema, defective body wall closure, and skeletal abnormalities. In the thorax, sternocostal connections were arranged asymmetrically and sternebrae were fused, defects that were phenocopied in EphB2/EphB3 receptor mutants. In the wrist, loss of ephrinB1 led to abnormal cartilage segmentation and the formation of additional skeletal elements. We conclude that ephrinB1 and B class Eph receptors provide positional cues required for the normal morphogenesis of skeletal elements. Another malformation, preaxial polydactyly, was exclusively seen in heterozygous females in which expression of the X-linked ephrinB1 gene was mosaic, so that ectopic EphB-ephrinB1 interactions led to restricted cell movements and the bifurcation of digital rays. Our findings suggest that differential cell adhesion and sorting might be relevant for an unusual class of X-linked human genetic disorders, in which heterozygous females show more severe phenotypes than hemizygous males.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919674     DOI: 10.1016/s1534-5807(03)00198-9

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  99 in total

1.  A culture system for the live analysis of successive developmental processes and the morphological control of mammalian vertebral cartilage.

Authors:  Yuichi Aono; Yohei Hirai
Journal:  Cytotechnology       Date:  2011-01-30       Impact factor: 2.058

Review 2.  Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis.

Authors:  Eduard Batlle; David G Wilkinson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

3.  Possible role of Efnb1 protein, a ligand of Eph receptor tyrosine kinases, in modulating blood pressure.

Authors:  Zenghui Wu; Hongyu Luo; Eric Thorin; Johanne Tremblay; Junzheng Peng; Julie L Lavoie; Yujia Wang; Shijie Qi; Tao Wu; Jiangping Wu
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

Review 4.  Eph/ephrin molecules--a hub for signaling and endocytosis.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 5.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

6.  EphB receptors and ephrin-B3 regulate axon guidance at the ventral midline of the embryonic mouse spinal cord.

Authors:  Stephanie R Kadison; Taija Mäkinen; Rüdiger Klein; Mark Henkemeyer; Zaven Kaprielian
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

7.  Ephrin-B2 forward signaling regulates somite patterning and neural crest cell development.

Authors:  Alice Davy; Philippe Soriano
Journal:  Dev Biol       Date:  2006-12-19       Impact factor: 3.582

8.  Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1.

Authors:  M E P van den Elzen; S R F Twigg; J A C Goos; A J M Hoogeboom; A M W van den Ouweland; A O M Wilkie; I M J Mathijssen
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

9.  Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.

Authors:  Tetsuo Ohnishi; Takuya Murata; Akiko Watanabe; Akiko Hida; Hisako Ohba; Yoshimi Iwayama; Kazuo Mishima; Yoichi Gondo; Takeo Yoshikawa
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

10.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.